The cost burden of Crohn’s disease and ulcerative colitis depending on biologic treatment status – a Danish register-based study

Abstract Background Patients diagnosed with inflammatory bowel disease may be treated with biologics, depending on several medical and non-medical factors. This study investigated healthcare costs and production values of patients treated with biologics. Methods This national register study included...

Full description

Bibliographic Details
Main Authors: Sarah Alulis, Kasper Vadstrup, Jens Olsen, Tine Rikke Jørgensen, Niels Qvist, Pia Munkholm, Andras Borsi
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Health Services Research
Subjects:
IBD
CD
Online Access:https://doi.org/10.1186/s12913-021-06816-3